An edition of Stem Cells in Regenerative Medicine
(2015)
Stem cells in regenerative medicine
science, regulation and business strategies
by Alain A. Vertes, Nasib Qureshi, Arnold I. Caplan, and Lee E. Babiss
- 0 Ratings
- 0 Want to read
- 0 Currently reading
- 0 Have read
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Previews available in: English
Subjects
Medicine, Stem cells, Regenerative medicine| Edition | Availability |
|---|---|
1
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2016, Wiley & Sons, Limited, John
in English
1118846192 9781118846193
|
zzzz
Libraries near you:
WorldCat
|
|
2
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English
1118846206 9781118846209
|
zzzz
Libraries near you:
WorldCat
|
|
3
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English
1119077877 9781119077879
|
zzzz
Libraries near you:
WorldCat
|
|
4
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
2015, Wiley & Sons, Incorporated, John
in English
1118846214 9781118846216
|
zzzz
Libraries near you:
WorldCat
|
5
Stem cells in regenerative medicine: science, regulation and business strategies
2015, John Wiley & Sons, Ltd
in English
111997139X 9781119971399
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Table of Contents
Therapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes
Ethical considerations on the research and business of stem cells / Ljiljana Minwalla
Projected growth of the worldwide stem cell market / Ed Field
Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith
The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson
Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber
The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies
The business of stem cell research tools / Erik Miljan
Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine
Stem cell tools for compound development / Tom Novak
Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar
The market of stem cell medicines for domestic and high value animals / Bob J. Harmann
Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone
Stem cells in veterinary medicines: a practical approach / Bob J. Harmann
Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes
Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr.
Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra
Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller
Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu
Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss
Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati
Hematopoietic stem cells / Steve Wolpe and Lynnet Koh
MSCs: the new medicince / Arnold Caplan
Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku
Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving
Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar
Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi
Challenges in the clinical development of stem cells / John Caulfield
Pricing and reimbursement of regenerative medicines / Nathan Dowden
The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo
Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio
Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith
History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden
Deployment of stem cell technologies in industry and healthcare/ Alain Vertes.
Edition Notes
Includes bibliographical references and index.
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
| February 3, 2023 | Edited by ImportBot | import existing book |
| September 21, 2020 | Edited by MARC Bot | import existing book |
| August 24, 2020 | Created by ImportBot | import new book |